← Browse by Condition

Medical Condition

neuroblastoma

Total Trials

11

Recruiting Now

11

Trial Phases

Phase 2, Phase 1, Phase 2, Phase 3

Biomarkers of Resiliency In Childhood Cancer Surgery

NCT06013618 Phase 2

Clinical Analysis of Naxitamab (hu3F8) in the Treatment of Pediatric High Risk or Refractory/ Relapsed Neuroblastoma

Sun Yat-Sen University Cancer ...

NCT03966651 Phase 1

A Clinical Study Evaluating the Safety of Peptide Receptor Radionuclide Therapy (PRRT) With 177Lu-DOTA0-Tyr3-Octreotate in Children With Refractory or Recurrent Neuroblastoma Expressing Somatostatin Receptors.

Institut Claudius Regaud

Abdominal Neuroblastoma Laparoscopic Surgery Risk Factors Stratification

Federal Research Institute of ...

NCT06988475 Phase 2, Phase 3

DETERMINE Trial Treatment Arm 06: Capmatinib in Adult Patients With Cancers Harbouring MET Dysregulations

Cancer Research UK

NCT00107289 Phase 2

Iodine I 131 Metaiodobenzylguanidine in Treating Patients With Recurrent, Progressive, or Refractory Neuroblastoma or Malignant Pheochromocytoma or Paraganglioma

Memorial Sloan Kettering Cance...

NCT06541262 Phase 1, Phase 2

Silmitasertib (CX-4945) in Combination With Chemotherapy for Relapsed Refractory Solid Tumors

United States, Canad...

Milton S. Hershey Medical Cent...

NCT04337177 Phase 1

Flavored, Oral Irinotecan VAL-413 (Orotecan®) Given With Temozolomide for Treatment of Recurrent Pediatric Solid Tumors

Valent Technologies, LLC

NCT02679144 Phase 2

Neuroblastoma Maintenance Therapy Trial

United States, Canad...

Giselle Sholler

Familial Investigations of Childhood Cancer Predisposition

St. Jude Children's Research H...

NCT06631391 Phase 1

Phase I Study of Umbilical Cord Blood Natural Killer (NK) Cell Therapy for Children With High-risk, R/R Neuroblastoma.

Sun Yat-sen University